Propranolol in portal hypertension: problems in paradise?

Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?

Hepatology (Baltimore, Md.)·2001

Portal hypertension, varices, and transjugular intrahepatic portosystemic shunts.

Clinics in liver disease·2001

Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis.

Surgery·2001

Hyperammonemia and intracranial hypertension: lying in wait for patients with hepatic disorders?

The American journal of gastroenterology·2000

Recurrent Crohn's disease in transplanted bowel.

Lancet (London, England)·1997

Interpretation of data from multiple trials: a critical review.

Journal of internal medicine·1997

Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

Hepatology (Baltimore, Md.)·2026

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Hepatology (Baltimore, Md.)·2026

Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

Hepatology (Baltimore, Md.)·2026

Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.

Hepatology (Baltimore, Md.)·2026

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

Hepatology (Baltimore, Md.)·2026

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Hepatology (Baltimore, Md.)·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

Propranolol in portal hypertension: problems in paradise?

Related Concept Videos

Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?

Portal hypertension, varices, and transjugular intrahepatic portosystemic shunts.

Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis.

Hyperammonemia and intracranial hypertension: lying in wait for patients with hepatic disorders?

Recurrent Crohn's disease in transplanted bowel.

Interpretation of data from multiple trials: a critical review.

Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.

A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.

Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.

Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

With no lysine kinase 1 in hepatic stellate cells promotes mouse and human liver fibrosis through glycolytic triosephosphate isomerase 1.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

Propranolol in portal hypertension: problems in paradise?

Related Concept Videos

Related Articles